Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -79.62%3.2M | -57.57%34.96M | -87.65%1.91M | -69.91%6.73M | -58.26%10.69M | -17.46%15.69M | 0.70%82.4M | -50.22%15.43M | 107.98%22.36M | 29.38%25.6M |
| Cost of revenue | -77.90%3.23M | -61.09%29.6M | -88.72%1.78M | -68.83%6.59M | -60.34%9.53M | -18.15%14.63M | -1.19%76.07M | -44.30%15.77M | 99.91%21.13M | 27.81%24.04M |
| Gross profit | -103.52%-37K | -15.20%5.37M | 136.34%125K | -88.36%144K | -26.26%1.15M | -6.49%1.05M | 30.71%6.33M | -112.86%-344K | 568.65%1.24M | 59.53%1.57M |
| Operating expense | -10.52%621K | 13.63%6.83M | 2.58%956K | 92.71%1.11M | 39.46%1.34M | 3.12%694K | 80.17%6.01M | -17.08%932K | -16.88%576K | 6.33%958K |
| Staff costs | ---- | 7.91%3.19M | ---- | ---- | ---- | ---- | 20.22%2.96M | ---- | ---- | ---- |
| Selling and administrative expenses | -26.13%800K | 34.37%4.49M | 2.58%956K | 92.71%1.11M | 39.46%1.34M | 23.91%1.08M | --3.34M | --932K | -16.88%576K | 6.33%958K |
| -General and administrative expense | -26.13%800K | 34.37%4.49M | 2.58%956K | 92.71%1.11M | 39.46%1.34M | 23.91%1.08M | --3.34M | --932K | -16.88%576K | 6.33%958K |
| Depreciation and amortization | ---- | 23.07%2.36M | ---- | ---- | ---- | ---- | 472.45%1.92M | ---- | ---- | ---- |
| -Depreciation | ---- | 23.07%2.36M | ---- | ---- | ---- | ---- | 472.45%1.92M | ---- | ---- | ---- |
| Other operating expenses | ---- | 9.05%1.32M | ---- | ---- | ---- | ---- | 20.86%1.21M | ---- | ---- | ---- |
| Total other operating income | -53.98%179K | -44.75%41.02K | ---- | ---- | ---- | 93.53%389K | -83.80%74.25K | ---- | ---- | ---- |
| Operating profit | -283.80%-658K | -566.38%-1.47M | 34.87%-831K | -246.14%-966K | -129.98%-182K | -20.80%358K | -79.08%314.49K | -182.30%-1.28M | 230.12%661K | 658.75%607K |
| Net non-operating interest income (expenses) | -562.50%-111K | -79.14%55.91K | -337.14%-83K | -119.78%-18K | -90.80%8K | -64.18%24K | 9.94%268K | -64.56%35K | 46.77%91K | 89.13%87K |
| Non-operating interest income | ---- | -81.09%69.1K | ---- | ---- | -90.80%8K | ---- | 21.16%365.39K | ---- | ---- | 89.13%87K |
| Non-operating interest expense | ---- | -88.29%11.19K | ---- | ---- | ---- | ---- | 192.30%95.59K | ---- | ---- | ---- |
| Total other finance cost | ---- | 10.78%1.99K | ---- | ---- | ---- | ---- | -92.84%1.8K | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | -91.33%3.28K | ||||||||
| Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | 91.33%-3.28K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 0.97%819.78K | -180.66%-196K | 402.33%1.08M | 0.93%216K | 11.45%811.92K | 202.32%243K | -62.48%215K | 3.88%214K | ||
| Income before tax | -301.31%-769K | -142.29%-591.02K | -11.22%-1.11M | -90.07%96K | -95.37%42K | -26.40%382K | -44.39%1.4M | -168.85%-998K | 661.42%967K | 173.49%908K |
| Income tax | 0 | 493.00%24.93K | 243.75%23K | 0 | 0 | 0 | -129.51%-6.34K | -174.42%-16K | 10K | 0 |
| Net income | -301.31%-769K | -143.87%-615.95K | -15.38%-1.13M | -89.97%96K | -95.37%42K | -26.40%382K | -43.66%1.4M | -168.77%-982K | 653.54%957K | 173.49%908K |
| Net income continuous operations | -301.31%-769K | -143.87%-615.95K | -15.38%-1.13M | -89.97%96K | -95.37%42K | -26.40%382K | -43.66%1.4M | -168.77%-982K | 653.54%957K | 173.49%908K |
| Noncontrolling interests | -554.55%-72K | -514.68%-348.62K | -3,400.00%-198K | -250.00%-36K | -547.83%-103K | -136.67%-11K | 97.38%84.07K | 131.48%6K | 14.29%24K | 1,050.00%23K |
| Net income attributable to the company | -277.35%-697K | -120.25%-267.33K | 5.36%-935K | -85.85%132K | -83.62%145K | -19.63%393K | -46.11%1.32M | -169.31%-988K | 780.19%933K | 168.18%885K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -277.35%-697K | -120.25%-267.33K | 5.36%-935K | -85.85%132K | -83.62%145K | -19.63%393K | -46.11%1.32M | -169.31%-988K | 780.19%933K | 168.18%885K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -271.43%-0.0012 | -120.83%-0.0005 | 16.67%-0.0015 | -88.24%0.0002 | -87.50%0.0002 | -22.22%0.0007 | -45.45%0.0024 | -172.00%-0.0018 | 750.00%0.0017 | 166.67%0.0016 |
| Diluted earnings per share | -271.43%-0.0012 | -120.83%-0.0005 | 16.67%-0.0015 | -88.24%0.0002 | -87.50%0.0002 | -22.22%0.0007 | -45.45%0.0024 | -172.00%-0.0018 | 750.00%0.0017 | 166.67%0.0016 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.